|
![]() |
|
|
Cefzil: profile and news
First-Time Generic Approvals: Zithromax, Cefzil, Zonegran Jan 27, 2006 Bristol-Myers Squibb Company Reports Financial Results for the ... Jan 25, 2006 for Oral Suspension Jan 18, 2006 UPDATE 2-Bristol-Myers sees 2006 profit falling 13-20 pct Jan 25, 2006 Bristol-Myers Catches a Cold Jan 25, 2006 Bristol earnings up, but issues warning Jan 25, 2006 FDA approves Teva antibiotic Cefprozil 11 Dec 2005 Dongkuk Steel, Hon Hai, Hyundai: Asia Ex-Japan Equity Preview Dec 9, 2005 Book Review - The PDR Family Guide to Prescription Drugs Sep 17, 2005 Free Health Stuff for Your Kids Aug 19, 2005 Bristol-Myers Quarterly Profit Increases, Helped by Plavix Drug Jul 28, 2005 Free Health Stuff for Your Kids Jun 21, 2005 Free Health Stuff for Your Kids Jun 21, 2005 Bristol-Myers Squibb Reports First Quarter 2005 Results in Line ... Apr 28, 2005 Bristol-Myers Squibb Reports First Quarter 2005 Results in Line ... 28 Apr 2005 Other information Indication For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph Pharmacology Cefprozil, a semisynthetic, second-generation cephalosporin, is used to treat otitis media, soft-tissue infections, and respiratory tract infections. Mechanism Of Action Cefprozil, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefprozil interferes with an autolysin inhibitor. Drug Category Anti-bacterial Agents; Cephalosporins; ATC:J01DC10 Brand Names/Synonyms Arzimol; Brisoral; Cefprozil anhydrous; Cefprozilo [INN-Spanish]; Cefprozilum [INN-Latin]; Cefzil; Cronocef; Procef; Serozil Dosage Forms Cefzil tablets contain cefprozil equivalent to 250 mg or 500 mg of anhydrous cefprozil. Absorption Oral_~95% Interactions Nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporin antibiotics. Concomitant administration of probenecid doubled the AUC for cefprozil. The bioavailability of the capsule formulation of cefprozil was not affected when administered 5 minutes following an antacid. Chemical IUPAC Name 8-[2-amino-2-(4-hydroxyphenyl)-acetyl]amino-7-oxo-4-prop-1-enyl-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylicacid Chemical Formula C18H19N3O5S Half Life 1.3 hours Drug Type Approved Drug # Accession No APRD00461 CAS Registry Number 92665-29-7 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |